Mitsubishi Tanabe Pharma Corporation v. Apotex Inc. et al
Mitsubishi Tanabe Pharma Corporation |
Apotex Inc. and Apotex Corp. |
1:2024cv00549 |
May 3, 2024 |
US District Court for the District of Delaware |
Jennifer L Hall |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on June 27, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Pro Hac Vice Attorney Jillian M. Schurr for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
Filing 22 STIPULATION TO EXTEND TIME for the parties to submit (1) a stipulation to consolidate; (2) a proposed scheduling order; and (3) a joint letter to July 8, 2024 - filed by Mitsubishi Tanabe Pharma Corporation. (Clark, Cameron) |
Filing 21 Pro Hac Vice Fee - Credit Card Payment received for Jillian M. Schurr. ( re #20 MOTION for Pro Hac Vice Appearance of Attorney Jillian M. Schurr )( Payment of $ 50, receipt number ADEDC-4438466).(Bilson, David) |
Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Jillian M. Schurr - filed by Apotex Corp., Apotex Inc.. (Attachments: #1 Certification of Jillian M. Schurr)(Bilson, David) |
![]() |
Pro Hac Vice Attorneys Yuki Onoe and Nao Takada for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
Filing 19 ANSWER to #14 Answer to Complaint, Counterclaim by Mitsubishi Tanabe Pharma Corporation.(Tigan, Jeremy) |
Pro Hac Vice Attorney Evan Smith for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
Pro Hac Vice Attorney Frank J. West for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
Pro Hac Vice Attorney Sara Pistilli for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
Pro Hac Vice Attorney Andrew M. Ollis for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
Pro Hac Vice Attorney Joseph M. Janusz for Apotex Corp., Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
![]() |
Filing 17 Pro Hac Vice Fee - Credit Card Payment received for Nao Takada. ( re #15 MOTION for Pro Hac Vice Appearance of Attorney Frank J. West, Andrew M. Ollis, Yuki Onoe, Evan C. Smith, and Sara M. Pistilli )( Payment of $ 50, receipt number ADEDC-4417467).(Tigan, Jeremy) |
Filing 16 Pro Hac Vice Fee - Credit Card Payment received for Frank J. West, Andrew M. Ollis, Yuki Onoe, Evan C. Smith, and Sara M. Pistilli. ( re #15 MOTION for Pro Hac Vice Appearance of Attorney Frank J. West, Andrew M. Ollis, Yuki Onoe, Evan C. Smith, and Sara M. Pistilli )( Payment of $ 250, receipt number ADEDC-4417462).(Tigan, Jeremy) |
Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Frank J. West, Andrew M. Ollis, Yuki Onoe, Evan C. Smith, Sara M. Pistilli, and Nao Takada - filed by Mitsubishi Tanabe Pharma Corporation. (Tigan, Jeremy) Modified on 5/29/2024 (ceg). |
![]() |
Filing 14 ANSWER to #1 Complaint Affirmative Defenses, COUNTERCLAIM against Mitsubishi Tanabe Pharma Corporation by Apotex Inc., Apotex Corp..(Phillips, John) |
Pro Hac Vice Attorney Lance A. Soderstrom for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (vfm) |
Pro Hac Vice Attorney Christopher B. Prescott for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (vfm) |
Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp.; Corporate Parent Apotex Holdco Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Deepro R. Mukerjee, Lance A. Soderstrom, Joseph M. Janusz, and Christopher B. Prescott. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Lance A. Soderstrom, Joseph M. Janusz and Christopher B. Prescott )( Payment of $ 200, receipt number ADEDC-4408673).(Bilson, David) |
Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Lance A. Soderstrom, Joseph M. Janusz and Christopher B. Prescott - filed by Apotex Corp., Apotex Inc.. (Attachments: #1 Certification of Deepro R. Mukerjee, #2 Certification of Lance A. Soderstrom, #3 Certification of Joseph M. Janusz, #4 Certification of Christopher B. Prescott)(Bilson, David) |
Filing 10 NOTICE of Appearance by David A. Bilson on behalf of Apotex Corp., Apotex Inc. (Bilson, David) |
Filing 9 NOTICE of Appearance by John C. Phillips, Jr on behalf of Apotex Corp., Apotex Inc. (Phillips, John) |
![]() |
DEFICIENCY NOTICE issued by the Court to Defendants: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (ceg) |
Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Apotex Inc. on May 3, 2024, filed by Mitsubishi Tanabe Pharma Corporation. (Tigan, Jeremy) |
Filing 7 AFFIDAVIT of Service for Summons, Complaint and related papers served on Apotex Corp. on May 3, 2024, filed by Mitsubishi Tanabe Pharma Corporation. (Tigan, Jeremy) |
Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (nms) |
Filing 6 Summons Issued as to Apotex Corp. on 5/3/2024; Apotex Inc. on 5/3/2024. (Attachments: #1 Summons Issued)(mpb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mitsubishi Chemical Group Corporation for Mitsubishi Tanabe Pharma Corporation filed by Mitsubishi Tanabe Pharma Corporation. (mpb) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,987,341 B2; 11,241,416 B2; 11,478,450 B2; 11,826,352 B2. (mpb) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/25/2024. Date of Expiration of Patent: 11/1/2039.Thirty Month Stay Deadline: 9/25/2026. (mpb) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
Filing 1 COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 405, receipt number ADEDC-4399458.) - filed by Mitsubishi Tanabe Pharma Corporation. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.